Cargando…
Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial
BACKGROUND: Effective anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) drugs are not only the next defense after vaccines but also the key part of establishing a multi-tiered coronavirus disease 2019 (COVID-19) prevention and control system. Previous studies had indicated that Lianh...
Autores principales: | Zhan, Yang-Qing, Chen, Rui-Feng, Zheng, Qing-Shan, Li, Xing-Wang, Liu, You-Ning, Mootsikapun, Piroon, Chayakulkeeree, Methee, Arttawejkul, Pureepat, Lan, Truong Thi Ngoc, Liu, Gordon G., Lu, Hong-Zhou, Liu, Qing-Quan, Zhong, Nan-Shan, Yang, Zi-Feng, Zheng, Jin-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267938/ https://www.ncbi.nlm.nih.gov/pubmed/37324081 http://dx.doi.org/10.21037/jtd-23-281 |
Ejemplares similares
-
Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial
por: Zheng, Jin-ping, et al.
Publicado: (2023) -
Effectiveness and Safety of Lianhua Qingwen Capsules for COVID-19: A Propensity-Score Matched Cohort Study
por: Lu, Yun, et al.
Publicado: (2023) -
The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule
por: Shen, Xuhui, et al.
Publicado: (2021) -
Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule
por: Lan, Xiao-fang, et al.
Publicado: (2021) -
Screening for Anti-Inflammation Quality Markers of Lianhua Qingwen Capsule Based on Network Pharmacology, UPLC, and Biological Activity
por: Zhou, Yongfeng, et al.
Publicado: (2021)